UnitedHealthCare (UNH) 2027 Medicare plans focus on affordability, simplicity and a more connected healthcare experience; more than 94% of Medicare-eligible individuals to have access to UnitedHealthcare plan in 2027
Every headline is on the live feed 20 minutes before this site.
US President Trump sees a ramping up of bombing Iran after midterms as possible, reports Time Magazine
US President Trump tells TIME that he likes Anthropic's Amodei a lot
UnitedHealthCare (UNH) 2027 Medicare plans focus on affordability, simplicity and a more connected healthcare experience; more than 94% of Medicare-eligible individuals to have access to UnitedHealthcare plan in 2027
Lilly's (LLY) oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease
Cardinal Health (CAH) extends its agreement with CVS Health (CVS) through June 2032
On the Newsquawk feed at , 20 minutes before this page.
- 90% of Medicare-eligible consumers to have USD 0 premium option in 2027
- 95% of medicare-eligible individuals to have access to HMO plan in 2027
- All members to have USD 0 primary Care visits and USD 0 tier 1 drug copays in 2027
Context
Annual Medicare Advantage plan filings and product launches of this kind are routine calendar items for the large managed care names, and the headline figures on premiums, copays and network breadth are standard competitive positioning rather than new information about the economics. What has historically mattered for the group is not the marketing shape of the plans but the rate environment underneath them: the gap between CMS benchmark rate increases and medical cost trend, and how it feeds through to margin guidance, has been the recurring driver of managed care multiples in recent cycles. Generous benefit designs, zero-premium options and rich copay structures signal a fight for membership share, which in past episodes has implied either confidence in the rate backdrop or acceptance of thinner margins to defend enrollment, and the distinction only becomes visible when bid assumptions and commentary accompany results. The follow-ons that have tended to carry the signal are the final rate notice, star ratings outcomes, and any color on utilization trends in the senior book, all of which have historically moved UNH and the Medicare-exposed peer set as a block. As a product announcement, this is descriptive rather than a pricing event; the equity read-through runs through margin framing, not plan features.
Related headlines
- Humana (HUM) affirms FY26 adj. EPS guidance of at least USD 9.003 hours ago
- EUROPEAN OPEN: AAPL cuts Oct iPhone 18 Pro component orders; AIR FP Sept deliveries flat Y/Y; SPCX agrees USD 8bln spectrum acquisition; ROP SW wins FDA approval for colon cancer drug; RBC expects MBG GY to issue a profit warning6 hours ago
- US BROKER MOVES: CBOE upgraded at Morgan Stanley; DD downgraded at JPM1 hour ago
- Micron (MU) says it plans to construct new fabrication facilities and/or ramp production at existing fabrication facilities to increase supply in to respond to a significant increase in demand for memory products1 hour ago
- US PRE-MARKET MOVERS: AAPL, SPCX, DAL, HUM/ALHC, LITE1 hour ago
- GlobalFoundries (GFS) unveils FDX Fusion FD-SOI platform for physical AI2 hours ago
- Netflix (NFLX) restructuring to impact roughly 5% employees and could be announces as early as next week, Puck reports citing sources2 hours ago
- Delta (DAL) CEO says it was a challenging quarter due to 60% rise in fuel costs, but maintained overall profitability; prices will rise further in Q42 hours ago
- Johnson & Johnson (JNJ) says 2-year ICOTYDE data in moderate-to-severe plaque psoriasis showed sustained efficacy through week 1123 hours ago
- AT&T (T) offers up to USD 1,200 off iPhone duo with eligible trade-in3 hours ago
- Eli Lilly (LLY) announces new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the concomitant use of Taltz and Zepbound in adults with Psoriasis and Obesity3 hours ago
- Delta Air Lines Inc. (DAL) Q3 2026 (USD): EPS 1.72 (exp. 1.76), Revenue 20.2bln (exp. 18.92bln). Current FY EPS 5.10-5.60 (exp. 5.43)3 hours ago
- China's CPCA says Tesla (TSLA) sold 95,366 Chinese-made vehicles in September4 hours ago
- Apple (AAPL) has reportedly told suppliers to cut production of components for its iPhone 18 and Pro Max as rising prices dampens consumer demand, Nikkei reports8 hours ago
- Nvidia (NVDA) plans to invest in chip competitor d-Matrix, according to The Information14 hours ago
- Apple (AAPL) product launch scheduled around Tuesday, October 27th; to debut touch-screen Mac and iPad Mini in late October18 hours ago
- Starbucks (SBUX) says it is 'laser-focused' on existing strategy following Chipotle (CMG) deal chatter, WSJ reports18 hours ago
- Coca-Cola (KO) is once again exploring a sale of Costa Coffee, according to Semafor, citing sources18 hours ago
- US lawmakers show concern over Google's (GOOGL) plan to acquire employee data from Spirit Airlines to train AI models, according to a letter18 hours ago
- TD Cowen see low odds for reported Starbucks (SBUX)-Chipotle (CMG) deal19 hours ago
The feed had this first.
Use the Platform